Discover
AUTL
Autolus Therapeutics plc
1.94
2 x 1.37
2 x 2.41
bid
ask
+
0.02
1.04%
2 @ 07:50 PM
1.95 +0.01 (0.52%)
| Ytd | -2.51% | |
| 1y | 42.65% |
1.88
day range
1.95
1.21
52 week range
2.54
| Open | 1.92 | Prev Close | 1.92 | Low | 1.88 | High | 1.95 | Mkt Cap | 516.36M |
| Vol | 1.77M | Avg Vol | 2.00M | EPS | -1.06 | P/E | N/A | Forward P/E | -3.08 |
| Beta | 2.10 | Short Ratio | 2.48 | Inst. Own | 77.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 1.94 | 200-d Avg | 1.65 | 1yr Est | 10.45 |
| Income Statement | |||
| Total Revenue | 45.69M | ||
| Revenues (USD) | 45.69M | ||
| Cost of Revenue | 20.47M | ||
| Gross Profit | 25.22M | ||
| Operating Expenses | 69.06M | ||
| Research and Development Expense | 27.90M | ||
| Selling, General and Administrative Expense | 41.16M | ||
| Operating Income | -43.84M | ||
| Interest Expense | -2.67M | ||
| Income Tax Expense | 465.00K | ||
| Net Income | -39.11M | ||
| Net Income Common Stock | -39.11M | ||
| Net Income Common Stock (USD) | -39.11M | ||
| Consolidated Income | -39.11M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -41.32M | ||
| Earning Before Interest & Taxes (USD) | -41.32M | ||
| Weighted Average Shares | 266.16M | ||
| Weighted Average Shares Diluted | 266.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 172.91M | ||
| Cash and Equivalents (USD) | 172.91M | ||
| Investments | 31.23M | ||
| Investments Current | 30.22M | ||
| Investments Non-Current | 1.02M | ||
| Trade and Non-Trade Receivables | 44.39M | ||
| Current Assets | 336.09M | ||
| Property, Plant & Equipment Net | 134.63M | ||
| Total Assets | 493.23M | ||
| Debt Current | 18.69M | ||
| Total Debt | 367.81M | ||
| Current Liabilities | 68.79M | ||
| Debt Non-Current | 349.12M | ||
| Total Liabilities | 418.39M | ||
| Accumulated Retained Earnings (Deficit) | -1.50B | ||
| Accumulated Other Comprehensive Income | -6.10M | ||
| Shareholders Equity | 74.84M | ||
| Shareholders Equity (USD) | 74.84M | ||
| Assets Non-Current | 157.14M | ||
| Total Debt (USD) | 367.81M | ||
| Goodwill and Intangible Assets | 18.53M | ||
| Inventory | 33.43M | ||
| Liabilities Non-Current | 349.60M | ||
| Trade and Non-Trade Payables | 1.84M | ||
| Tax Assets | 2.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.53M | ||
| Net Cash Flow from Financing | -2.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 40.49M | ||
| Capital Expenditure | -913.00K | ||
| Issuance (Purchase) of Equity Shares | 3.00K | ||
| Issuance (Repayment) of Debt Securities | -2.14M | ||
| Net Cash Flow from Investing | 67.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 68.81M | ||
| Net Cash Flow from Operations | -25.07M | ||
| Effect of Exchange Rate Changes on Cash | -199.00K | ||
| Share Based Compensation | 4.60M | ||